ClearMed
All Nephrology BriefingsKidney International
NephrologyReal-World Cohort2 min read

Estimating GFR: what it is, what it is not, and why prediction cannot settle the question

The analysis is cross-sectional, leaving longitudinal performance untested.

Published in Kidney InternationalObservational cohort study
3/5 Observational
Evidence Meter · 3/5

Real-World Observation

Finds meaningful patterns in human health records or cohorts, though observational data cannot prove direct cause.

Source

Real-World Observation

3/5

Equations are population tools; at the bedside, non-glomerular filtration rate determinants of both creatinine and cystatin C can mislead.

What Changes?

Nephrology · Real-World Cohort

Current Standard

Conventional nephrology practice relies on standard-of-care monitoring and existing regimens prior to this observational cohort study.

New Finding

We argue that prediction of kidney failure cannot validate a glomerular filtration rate equation: dialysis initiation is a clinical decision, not a filtration measurement.

3 Key Takeaways

Plain English Summary
  1. 01Core Finding

    Delivered via estimating GFR: what it is, what it is not, and why prediction cannot settle the, this real-world cohort approach targets Glomerular filtration & renal tubular preservation.

  2. 02Study Evidence

    Tested in a observational cohort study at the real-world cohort stage.

  3. 03Practical Meaning

    Observational cohort findings reveal real-world links, though lifestyle or unmeasured factors cannot be fully ruled out without an RCT.

What This Means for You

Equations are population tools; at the bedside, non-glomerular filtration rate determinants of both creatinine and cystatin C can mislead.

The Discovery

Schultheiss et al. show that replacing Chronic Kidney Disease Epidemiology Collaboration with European Kidney Function Consortium cystatin C-based equations reclassifies women, but not men, into milder chronic kidney disease stages, while outcome prediction is unchanged. We argue that prediction of kidney failure cannot validate a glomerular filtration rate equation: dialysis initiation is a clinical decision, not a filtration measurement. The analysis is cross-sectional, leaving longitudinal performance untested.

How It Works, Simply

This nephrology research focuses on glomerular filtration & renal tubular preservation. Researchers evaluated it using an observational cohort study at the real-world cohort stage of medical research.

3 Key Takeaways

Clinical Takeaways
  1. 01Core Finding

    Delivered via estimating GFR: what it is, what it is not, and why prediction cannot settle the, this real-world cohort approach targets Glomerular filtration & renal tubular preservation.

  2. 02Study Evidence

    Tested in a observational cohort study at the real-world cohort stage.

  3. 03Practical Meaning

    Observational cohort findings reveal real-world links, though lifestyle or unmeasured factors cannot be fully ruled out without an RCT.

01

Biological Mechanism & Study Design

Study Design & Cohort

Observational cohort study

Observational cohort study · Real-World Cohort

Biological Pathway & Modality

Glomerular filtration & renal tubular preservation

Intervention: Estimating GFR: what it is, what it is not, and why prediction cannot settle the

02

Experimental Findings & Endpoints

Schultheiss et al. show that replacing Chronic Kidney Disease Epidemiology Collaboration with European Kidney Function Consortium cystatin C-based equations reclassifies women, but not men, into milder chronic kidney disease stages, while outcome prediction is unchanged.

We argue that prediction of kidney failure cannot validate a glomerular filtration rate equation: dialysis initiation is a clinical decision, not a filtration measurement. The analysis is cross-sectional, leaving longitudinal performance untested.

03

Clinical Translation & Practice Context

Equations are population tools; at the bedside, non-glomerular filtration rate determinants of both creatinine and cystatin C can mislead.

03

The Bottom Line · Clinical Pearl

“Equations are population tools; at the bedside, non-glomerular filtration rate determinants of both creatinine and cystatin C can mislead.”

Published in Kidney International · Current Stage: Real-World Cohort

Nephrology · Real-World Cohort
Study Type
Observational cohort study

Observational cohort study

Evidence Score
3/5 · Real-World Observation
Evidence Meter · 3/5

Real-World Observation

Finds meaningful patterns in human health records or cohorts, though observational data cannot prove direct cause.

Finds meaningful patterns in human health records or cohorts, though observational data cannot prove direct cause.

Who It Applies To
Observational cohort study in nephrology care
Intervention & Mechanism
Estimating GFR: what it is, what it is not, and why prediction cannot settle the

Glomerular filtration & renal tubular preservation

Key Limitation
Observational cohort findings reveal real-world links, though lifestyle or unmeasured factors cannot be fully ruled out without an RCT.

Translational Stage

LEVEL 2 · Real-World Cohort

Classified as Observational cohort study along the clinical evidence continuum

  1. Lab & Discovery
  2. Early Trials
  3. Human Evidence
  4. 4Real-World CohortActive

Indexed Clinical Entities

Original Publication & AMA Citation

Estimating GFR: what it is, what it is not, and why prediction cannot settle the question. Kidney International. Published 2026;Nov 15. Accessed November 15, 2026. https://pubmed.ncbi.nlm.nih.gov/42901688/

Kidney International

https://pubmed.ncbi.nlm.nih.gov/42901688/

Read Original Paper

Continue Reading

Related in Nephrology

View all Nephrology briefings →
NEPHROLOGY · PRECLINICAL

Gut-targeted interventions to complement PTH-lowering therapy

These findings highlight the potential of gut-targeted interventions to complement established parathyroid hormone-lowering strategies for improving skeletal health. Secondary hyperparathyroidism is a major contributor to skeletal fragility in chronic kidney disease, yet fracture risk remains high despite parathyroid hormone-lowering therapy.

2/5 Preclinical
Evidence Meter · 2/5

Animal & Preclinical Data

Demonstrated in living animal models before large-scale human safety and dosing trials begin.

1 min readKidney International
NEPHROLOGY · PHASE I/II

Fingerprinting the polycystic kidney: radiomics of the noncystic parenchyma for earlier ADPKD detection

Small, cross-sectional, unmatched data require longitudinal validation of reproducibility, prognostic value, and clinical utility. Autosomal dominant polycystic kidney disease risk stratification relies on total kidney volume, a validated marker of cyst burden and progression.

3/5 Observational
Evidence Meter · 3/5

Real-World Observation

Finds meaningful patterns in human health records or cohorts, though observational data cannot prove direct cause.

1 min readKidney International
NEPHROLOGY · CLINICAL PRACTICE

Kidney stone disease: to drink or not to drink-that is the question

Effective prevention likely requires achieving a substantial increase in urine volume alongside comprehensive dietary and pharmacologic management. An important point to note is that these findings do not invalidate the protective role of increased urine volume but highlight the limitations of behavioral interventions alone.

3/5 Observational
Evidence Meter · 3/5

Real-World Observation

Finds meaningful patterns in human health records or cohorts, though observational data cannot prove direct cause.

1 min readKidney International